投資 Lifecore Biomedical Inc 股票，查看LFCR股票行情及趨勢

交易

概述

上一交易日收盤價 7.11

星期範圍 7.22 - 7.68

52 週範圍 3.66 - 8.61

平均交易量（3個月） 173.35K

1-年投資報酬 18.73%

Beta1.0729

市值 263.13M

市盈率119.88

收入128.45M

每股盈餘0.0596

股息 (收益率) 0 (0%)

行業

Health Technology

產業

Pharmaceuticals Major

執行長

Paul Josephs

員工

524

財務摘要

在31/5/2024結束的金融年度: Lifecore Biomedical Inc的營收increased by 24.20% ，達到 128.26M。淨利increased by 113.52%至9.33M。淨資產increased by 44.11%到53.90M；每股盈餘從-3.41increased到0.33。

損益表資產負債表現金流量表

每季

34.65%

-16.18%

-7.52%

-13.63%

08/23

02/24

05/24

08/24

24.52M

35.7M

37.89M

24.71M

2.73M

11.89M

17.27M

5.39M

-8.62M

-124K

2.89M

-11.1M

-12.61M

14.79M

-7.09M

-16.23M

LFCR Lifecore Biomedical Inc

概述

財務摘要